SHIFT Newsroom · GLOBAL
Glucagon-Like Peptide-1 Receptor Agonists for Obstructive Sleep Apnea: A Review
Researchers are investigating the potential of Glucagon-Like Peptide-1 Receptor Agonists in treating Obstructive Sleep Apnea, but more evidence is needed.
A new review has been published on the potential use of Glucagon-Like Peptide-1 Receptor Agonists in treating Obstructive Sleep Apnea. While this research is promising, more evidence is needed to fully understand the effectiveness and safety of this treatment.
SHIFT’s take
This research may have implications for the treatment of Obstructive Sleep Apnea in the UK, but it is still in the early stages and more evidence is required.
Known facts
- Glucagon-Like Peptide-1 Receptor Agonists are being investigated for the treatment of Obstructive Sleep Apnea.